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Abstract
Background: The coincidence of vascular smooth muscle cells (VSMC) infiltration and collagen deposition within a diffusely
thickened intima is a salient feature of central arterial wall inflammation that accompanies advancing age. However, the
molecular mechanisms involved remain undefined.
Methodology/Principal Findings: Immunostaining and immunoblotting of rat aortae demonstrate that a triad of
proinflammatory molecules, MCP-1, TGF-b1, and MMP-2 increases within the aortic wall with aging. Exposure of VSMC
isolated from 8-mo-old rats (young) to MCP-1 effects, via CCR-2 signaling, both an increase in TGF-b1 activity, up to levels of
untreated VSMC from 30-mo-old (old) rats, and a concurrent increase in MMP-2 activation. Furthermore, exposure of young
VSMC to TGF-b1 increases levels of MCP-1, and MMP-2 activation, to levels of untreated VSMC from old rats. This
autocatalytic signaling loop that enhances collagen production and invasiveness of VSMC is effectively suppressed by si-
MCP-1, a CCR2 antagonist, or MMP-2 inhibition.
Conclusions/Significance: Threshold levels of MCP-1, MMP-2, or TGF-b1 activity trigger a feed-forward signaling mechanism
that is implicated in the initiation and progression of adverse age-associated arterial wall remodeling. Intervention that
suppressed this signaling loop may potentially retard age-associated adverse arterial remodeling.
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Introduction
Coincident collagen deposition and vascular smooth muscle cell
(VSMC) cellularity within a diffusely thickened arterial intima is a
salient feature of species-wide mammalian arterial wall remodeling
that accompanies aging [1–3]. These age-associated alterations
create a metabolically active microenvironment, especially in the
thickened intima, and render it fragile, and vulnerable to
pathologic stimuli, e.g., a high cholesterol diet, in older persons
[1–7].
Novel insights into the cellular and molecular basis of this risk-
prone niche have been recently reported. With advancing age, the
proinflammatory biomolecules: monocyte chemoattractant pro-
tein-1 (MCP-1), matrix metalloproteinase type-II (MMP-2), and its
activator calpain-1, and transforming growth factor-beta 1 (TGF-
b1) become elevated within the arterial wall in numerous species,
including humans [8–14]. Moreover, MCP-1, MMP-2, and TGF-
b1 are also markedly elevated in early passage VSMC isolated
from old vs. young aortae [11,13]. Exposure of early passage
isolated VSMC from young rat aortae to MCP-1 or MMP-2 shifts
their phenotype to one resembling old untreated cells [11,13].
Specifically, MCP-1 increases the invasive capacity of young
VSMC to the level of their old counterparts; exposure of VSMC to
MMP-2 enhances the levels of activated TGF-b1, and conse-
quently increases the production of collagen types I and III, up to
that of old cells [11,13]. These findings suggest that an MCP-1/
MMP-2/TGF-b1 signaling loop may be operative and a key to the
collagen production and intimal invasion by VSMC, contributing
to the concurrence of fibrosis and cellularity in the thickened
intima of the aged arterial wall. Mutual interactions of these
molecules both in vitro and in vivo form a putative signaling loop
that is implicated in the histopathological features of the aged
arterial wall.
In the present study, we demonstrate, for the first time, that: 1)
co-expression of MCP-1 and TGF-b1 is increased within the aged
aortic wall; 2) MCP-1 treatment increases activation of TGF-b1
and its downstream signaling molecules, to produce collagen; 3)
MCP-1 also increases the invasive capability of young VSMC in
an MMP-2-dependent manner, to that level of old untreated cells;
4) following TGF-b1 treatment of young cells, MCP-1 production,
MMP-2 activation and VSMC invasion increase, reaching the
levels of untreated old cells. We demonstrate the existence of this
autocatalytic signaling loop that enhances collagen production and
invasiveness of VSMC, and that it can be effectively disabled by si-
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interventions aimed at any one of these local signaling loop
elements may potentially retard adverse age-associated arterial
remodeling.
Results
Increased MCP-1 and TGF-b1 co-localize within the aortic
wall of old rats
FXBN rats are a well-characterized animal model of cardio-
vascular aging with similarities to the human anatomic and
physiologic phenotype. MCP-1 and TGF-b1 increase within the
aortic wall, and both co-immunolabel with alpha-smooth muscle
actin (a-SMA), a marker of VSMC [9,11]. Double immunolabel-
ling shows that aortic MCP-1 (red), TGF-b1 (green) immunolabel-
ing, and their co-localization (merged image: yellow color) increase
in the aged rat aortic wall, predominantly within the thickened
intima in rats (Figure 1A, bottom right panel).
MCP-1 induces VSMC TGF-b1 protein expression,
activation, and secretion
To further investigate a link between MCP-1 and TGF-b1, we
isolated VSMC from young and old rats. Prior studies demon-
strated that cultured early passage (p3–5) VSMC maintain an age-
related typical inflammatory profile in vivo such as elevated levels
of MMP-2, MCP-1 and calpain-1[11,13,14]. Figure S1 shows
further that early passage (p3) VSMC also retain typical age-
associated characteristics as in vivo cells, including cytoskeleton
proteins, a-SMA, vimentin, and desmin. MCP-1 treatment of early
passage cells (p3) from young rats for 24 hr enhances levels of
TGF-b1 protein signal (Figure 1B), up to that of old untreated
cells. Treatment with MCP-1 induces cell-associated TGF-b1
protein expression in young rats, to an extent equivalent to that of
old, untreated cells (Figure 1C, right panel). Furthermore,
TGF-b1 secretion, as assessed via an ELISA, is significantly higher
in untreated old vs. young VSMC (Figure 1C, left panel).
MCP-1 also induces TGF-b1 protein secretion from young aortic
VSMC, up to levels of untreated old cells (Figure 1C, left
panel).
To define the location of cellular TGF-b1 within VSMC, we
performed Western blotting of the cellular protein subfractions
including cytosol, organelles, and nuclei of VSMC. TGF-b1
protein significantly increases in all subcellular fractions in old
versus young cells (Figure 2A). Interestingly, following MCP-1
treatment, subcellular activated TGF-b1 increased in young
VSMC in nuclei, cytosol, and organelle compartments, up to
the level of old untreated cells (Figure 2B).
MCP-1 also modulates the CCR2/MMP-2/TGF-b1
signaling axis
Our prior studies have demonstrated that MMP-2 and MCP-1
concurrently increase within the aged rat arterial wall, and that
MMP-2 activates TGF-b1 signaling via proteolysis [11,13]. An
age-associated increase in MMP-2 levels and activity may be
linked to increases in both MCP-1 and TGF-b1 and to increased
activation of the latter. We employed siRNA of MCP-1 to
determine its effects on MMP-2 activity within old VSMC. The
microphotograph in Figure 3A indicates the transfection
efficiency and location (perinuclear space, enlarged image). RT-
PCR shows that si-MCP-1 substantially decreases MCP-1 mRNA
abundance (Figure 3B). Correspondingly, Western blot analysis
indicated that si-MCP-1 substantially decreases MCP-1 protein
abundance (Figure 3C). Importantly, after silencing, not only is
MCP-1 protein reduced, but MMP-2 and TGF-b1 protein and
activation is also simultaneously reduced in a dose-dependent
fashion (Figure 3D & E).
Figure 4A shows that MCP-1 treatment of VSMC increases
MMP-2 activation (lowest weak bands) in a dose-dependent
manner. Further, the MCP-1-treatment associated MMP-2
activation in VSMC is substantially reduced by vCCI, a blocker
of the cognate MCP-1 receptor (Figure 4B).
MMP-2 activity links MCP-1 to TGF-b1 signaling. PAGE
zymogram indicates that MCP-1 in young VSMC markedly
increases MMP-2 activation, which is abolished by a neutralizing
antibody against MMP-2 (Figure 4C). Western analysis shows
that the MCP-1 markedly increases the activated form of TGF-b1,
and significantly increases the expression of its downstream
signaling molecule, procollagen type I, which is diminished by a
neutralizing antibody against MMP-2 in young VSMC
(Figure 4D). Notably, the abundance of protein and activity of
TGF-b1 in old VSMC also decreases after MCP-1 silencing
(Figure 3 D&E).
MMP-2 signaling links MCP-1 to VSMC invasion
Prior studies indicate that MCP-1/CCR-2 signaling and MMP-
2 activation are both involved in the age-associated increase in the
ability of rat VSMC to invade basement membranes [9,11,13].
Here, we performed an additional series of experiments to address
the details of this interaction. Figure 5A shows that invasion
through a matrigel membrane of early passage VSMC from aged
rats in response to a PDGF-BB gradient is increased by over 60%
compared to that of VSMC from young rats. MCP-1 treatment
(50 ng/ml, 24 hour) enhances the ability of VSMC isolated from
young rats to invade the matrigel membrane by 40%, i.e., to that
level of untreated old VSMC (Figure 5A). This effect was blunted
not only by the CCR2 blocker, vCCI (150 ng/ml), but
importantly, also by the metalloproteinase inhibitor, GM 6001
(15 mM) (Figure 5A). Importantly, MCP-1 silencing substantially
decreases the invasive capability of older cells (Figure 5B).
TGF-b1 increases MCP-1 expression, MMP-2 activation,
and VSMC Invasion
The results of the above experiments are attributable to an
MCP/MMP-2/TGF-b1 signaling loop and suggest that the
progressive arterial intimal thickening and accumulation of
cellularity and fibrosis within the thickened intima during aging
may involve this feed-forward signaling. If this were the case,
activated TGF-b1 should lead to an increase in MCP-1 protein,
MMP-2 activation, and affect the VSMC invasion phenotype.
Figure 6A demonstrates that exposure of young VSMC to TGF-
b1 indeed increases both MCP-1 abundance and secreted
activated MMP-2 in a dose-dependent manner, reaching levels
of untreated old cells; and that exposure of young VSMC to TGF-
b1 also enhances their invasive capacity, which approaches that of
old untreated cells (Figure 6B). Interestingly, RT-PCR show that
exposure of young VSMC to TGF-b1 (100 ng/ml) for 24 h didn’t
affect levels of MCP-1 mRNA compared to control (1.8560.41
vs.1.8860.21, p.0.05).
Discussion
The novel findings of this study support the idea that a feed-
forward, MCP-1/MMP-2/TGF-b1, proinflammatory signalling
loop triad, as depicted schematically in Figure 7, sustains
processes that are associated with the arterial remodelling that
accompanies advancing age.
Arterial Aging Proinflammation Signaling Loop
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via its cognate receptor CCR-2. Active MMP-2 increases the active
form of TGF-b1 by its proteolytic effects on its latent forms, LAP and
LTBP-1 [13]. The active form of TGF-b1 enhances itself via a feed-
forward effect, by activating both MCP-1 and MMP-2. Active TGF-
b1 increases the activity of MMP-2, via a direct effect on its activation,
and an indirect effect via MCP-1/CCR2 signaling. MCP-1 maintains
its level indirectly via its effect to activate MMP-2, which activates
TGF-b1, which, in turn, increases MCP-1. Thus, each of these
molecules, MCP-1, MMP-2, and TGF-b1, are part of a feed-forward
loop that sustains each others level or activity and drives intimal
VSMC cellularity and fibrogenesis, salient features of arterial aging.
The triad of proinflammatory molecules not only are main-
tained in their levels of translation and activation in the aging
Figure 1. Age and MCP-1 effect on expression of TGF-b1. A. Immunofluorescence staining in rat aortic walls. MCP-1 (red), TGF-b1 (green),
merged (yellow). Original magnification: X400. B. TGF-b1 (green) and a-SMA (red) immunocytostaining (n=3, X400). C. ELISA for activated TGF-b1
protein (left panel) and Western blots (right panel, inset) and average data (right panel). Early passage young and old VSMC were treated with or
without MCP-1 (50 ng/ml) for 24 hours. *p,0.05, old vs. young control; #p,0.05, young with treatment of MCP-1 v.s. young control.
doi:10.1371/journal.pone.0016653.g001
Arterial Aging Proinflammation Signaling Loop
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e16653arterial wall or cells, but also may be linked at the transcription
level. Our prior studies show that the transcription levels of MCP-
1, MMP-2, and TGF-b1, increases in the aged arterial wall in situ
and in aged VSMC in vitro [9-13]. Most recently, a micro-RNA,
i.e., MiR-21, has emerged as a potential modulator of transcrip-
tional coregulation of TGF-b1 and MMP-2 [15,16].
Fibrotic signaling via the MCP-1/MMP-2/TGF-b1 cascade is
increased within both the old arterial wall and early passage
VSMC isolated from the aortic wall, and may modulate
progressive arterial fibrogenesis with aging. Indeed, exposure of
young VSMC to exogenous MCP-1 enhances MMP-2 activation
and consequently elevates TGF-b1 activation and collagen
Figure 2. Age effects on subcellular distribution of TGF-b1. A. Western blots of TGF-b1 subcellular fractions with aging (upper panels) and
average data of subcellular TGF-Y1 protein fractions lower panel). B. Representative Western blots of TGF-b1 subcellular fractions with aging and
MCP-1 treatment. Similar results were obtained from at least 3 separate experiments. Early passage young and old VSMC were treated with or
without MCP-1 (50 ng/ml) for 24 hours. *p,0.05, old vs. young.
doi:10.1371/journal.pone.0016653.g002
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substantially reduced by a CCR-2 blocker or an MMP-2 inhibitor.
Importantly, age-elevated endogenous TGF-b1 and its consequent
signaling product collagen type I in old VSMC return to levels of
young cells after silencing of MCP-1, blockade of CCR-2
signaling, or inhibition of MMP-2 activation. These findings
further expand the prior concept that MMP-2 activation induces
matrix production via TGF-b1 activation in VSMC with aging
[13]. In addition, our findings, for the first time, suggest that TGF-
b1, activated intracellularly and within the nucleus, is increased in
VSMC with aging, as in hepatic stellate cells and hepatocytes after
injury [13,17-19], and may play a role in the initiation and
progression of VSMC aging via epigenetic modulation in an
intracrine manner.
Our results demonstrate that MCP-1/MMP-2/TGF-b1 loop
signaling not only promotes VSMC fibrogenesis, but also facilitates
Figure 3. siRNA MCP-1. A. Photomicrograph of MCP-1 silenced VSMC. Inset showing enlarged image (X1000). B. qRT-PCR. *p,0.05, siRNA MCP-1
vs. scramble in 30 mo VSMC. C. Western blots of MCP-1 in 30 mo VSMC (n=3). D. Immunofluoscence staining of MCP-1 (green), MMP-2 (red), and
TGF-b1 (red) (X400) in 30 mo VSMC treated with scramble (upper panels) and MCP-1 (50 nm, lower panels) siRNA. E. Representative of Western blots
for MCP-1 and TGF-b1 and PAGE gelatin zymograph. Similar results were obtained from at least 3 separate experiments. *p,0.05 vs. scramble control.
doi:10.1371/journal.pone.0016653.g003
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PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e16653Figure 4. Profile of MMP-2, TGF-b1 and downstream signaling molecules with aging and MCP-1 intervention. A. Gelatin zymograph. Early
passage young VSMC were treated with or without MCP-1 for 24 hours. B. Gelatin zymograph (upper panel); and average data (lower panel). Early
passage young and old VSMC were treated with or without MCP-1 (50 ng/ml) plus vCCI (100 ng/ml) for 24 hours. C. Gelatin zymograph (n=3). Early
passage young VSMC were treated with or without MCP-1 (50 ng/ml) plus neutralizing antibody against MMP-2 (2 mg/ml) for 24 hours. D.
Representative Western blots of MCP-1 and collagen I after MCP-1 treatment (left panels) and average data (right panels). Early passage young VSMC
were treated with or without MCP-1 (50 ng/ml) plus neutralizing antibody against MMP-2 (2 mg/ml) for 24 hours. *p,0.05, vs. young; #p,0.05, vs
MCP-1 treatment alone.
doi:10.1371/journal.pone.0016653.g004
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to intimal thickening. Our findings show that MCP-1 increases
invasiveness of VSMC during aging via a triad effect: by activation
of MMP-2 and by its chemoatractant signaling via the MCP-1
receptor, CCR2, as well as by activation of TGF-b1. The present
and prior studies [11] show that in response to PDGF-BB (1) the
invasiveness of MCP-1 treated young VSMC increases up to the
level ofuntreated oldVSMC,an effect that is abolishedbyGM6001
or vCCi; and (2) the enhanced invasiveness of old VSMC is blunted
by MCP-1 silencing, vCCi, or GM-6001. Thus, current and prior
findings [20] suggest that MCP-1 and MMP-2 are directtargets and
mediators of TGF-b1-induced VSMC invasion.
Accumulating evidence indicates that sustained, age-associated
increases in transcription, translation and activation of the triad of
proinflammatory modulators MCP-1, MMP-2, and TGF-b1 [8–13],
is linked to the arterial wall Ang II signaling cascade in rodents,
nonhuman primates and humans [2,3,9,14]. Indeed, the invasive
capacity of young medial VSMC induced by both Ang II and its
downstream signaling molecule, milk fat globule-EGF-8 (MFG-E8)
mediated by MCP-1 signaling are increased, approaching the levels of
untreated old cells [8,21]. This Ang II orchestration of triad signaling
potentially governs the initiation and progression of age-associated
arterial intimal cellularity and collagen deposition in a feed-forward
mechanism by which threshold amounts of MCP-1, MMP-2, or
TGF-b1 activates the loop triad, triggering a positive developmental
cascade. This feed-forward positive signaling loop, however, does not
function in isolation, but is tightly controlled by a complex signaling
network, including its suppression by insulin like growth factor
binding protein-7 (IGFBP-7) and tissue inhibitor of metalloprotei-
nases-2 (TIMP-2) signaling that change with aging [13,21]. It is likely
that, over the long period of time over which aging occurs a chronic
imbalance of the signaling loop herein and other suppressive signaling
enables the induction of VSMC invasion and collagen deposition
within the arterial wall. Similar Ang II-related activation of molecular
and cellular events also occurs within the neointima or atheroscler-
oma formation during the early stages of arterial injury and
atherosclerosis and hypertension, respectively [22–30]. Thus, arterial
wall aging could be construed as a journey into a subclinical vascular
disease state, and targeting this feed-forward system is a novel
potential approach to sustain arterial health with advancing age.
Materials and Methods
Animals
Male Fisher 344 crossbred Brown Norway rats (FXBN), 8-
month-old (8mo: n=20) and 30-month-old (30mo: n=20), were
obtained from the National Institute on Aging Contract Colonies
(Harlan Sprague Dawley, Inc, Indianapolis, IN). All of the animals
were sacrificed immediately by an overdose of sodium pentobar-
bital, and the thoracic aortae were immediately removed, isolated,
and processed as described previously [9,11,13,14]. The animal
protocols (EGL-Ra210) used were approved by the Institutional
Animal Care and Use Committee of the Gerontology Research
Center and complied with the guide for the care and use of
laboratory animals (NIH publication No. 3040-2, revised 1999).
Figure 5. VSMC Invasion. A. VSMC treated with or without MCP-1
(50 ng/ml) plus vCCi (150 ng/ml) or GM 6001 (15 mM). *p,0.05, vs.
young; #p,0.05, vs MCP-1 treatment alone. B. Old VSMC with or
without si-MCP-1 (50 nM). *p,0.05 si-MCP-1 vs. scramble control.
doi:10.1371/journal.pone.0016653.g005
Figure 6. Effects of TGF-b1 on young VSMC. A. Representative
Western blots of MCP-1 (upper panel) and b-actin (lower panel) and
zymograph (middle panel). B. VSMC invasion. Early passage young and
old VSMC were treated with or without TGF-b1 (1, 10, 100 ng/ml) for
24 hours. *p,0.05, vs. young; #p,0.05, TGF-b1 treatment vs young.
doi:10.1371/journal.pone.0016653.g006
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Thoracic aortae frozen sections and cultured VSMC were
incubated overnight at 4uC with primary antibodies diluted in
accordance with the manufacturer’s instructions. Tissue sections
were further incubated with secondary, fluorescence conjugated
antibodies, and photomicrographs were acquired by a computer-
imaging program (MetaMorph Imaging System, Universal
Imaging Corp., PA). All immunostaing was performed on frozen
aortic sections from at least 4 animals. The source and
characteristics of primary antibodies used were listed in Table 1.
VSMC Isolation, culture, and treatment
Vascular smooth muscle cells were enzymatically isolated and
cultured as previously described [11]. Briefly, F344XBN rat thoracic
aortas were rinsed in Hanks balanced salt solution (HBSS) containing
50 mg/mL penicillin, 50 mg/mL streptomycin and 0.25 mg/mL
amphotericin B (Gibco). After digestion for 30 min in 2 mg/mL
collagenase I solution (Worthington Biomedical, Freehold, New
Jersey) at 37uC, the adventitia and intima were removed from the
vessel media layer, which was placed overnight in complete medium
(DMEM plus 10% FCS). On day 2 the vascular media was further
digested with 2 mg/mL collagenase II/0.5 mg/mL elastase (Sigma)
for 1 hour at 37uC, and the isolated cells were washed and plated in
complete medium. In all cases, .95% of cells stained positive for a-
smooth muscle actin (a-SMA).
Early passage (p3) VSMC were treated with or without MCP-
1(1, 10, 50 and 100 ng/ml, R&D research Inc., MN), TGF-b1 (1,
10, and 100 ng/ml, R&D research Inc., MN), vCCI (150 ng/ml,
R&D research Inc., MN), and a neutralizing antibody against
MMP-2 (2 mg/ml, R&D research Inc., MN) for 24 hours in 0.1%
FBS for PAGE zymography and Western blot analysis.
Western Blotting and Gel Zymography
VSMC plated on 100 mm petri dishes, were washed twice with
cold PBS, 80 mL of lysis buffer (LB: 20 mmol/L Tris-HCl, pH 7.5;
150 mmol/L NaCl; 1 mmol/L Na2EDTA, 1 mmol/L EGTA;
1% Triton; 1 mg/mL leupeptin; 1 mmol/L PMSF) were added,
and the cells scraped from the plate and transferred to 1.5 mL
tubes. Sub-cellular protein fractions were isolated according to the
manufacturer’s instructions (ProteoExtract kit, EMD Biosciences,
La Jolla, CA). Fifteen mg of proteins were resolved by SDS-PAGE
and transferred onto PVDF membranes (Immobilon). HRP-
conjugated IgG (Amersham Pharmacia Biotech) were used as
secondary antibodies and detected with SuperSignal West Pico
Chemiluminescent Substrate (Pierce Biotechnology). The source
and characteristics of primary antibodies used were listed in
Table 1.
Real time PCR
RNA was extracted from VSMC using Trizol reagent
(Invitrogen) following the manufacturer’s instructions. RNA
(500 ng) was reverse transcribed for 30 minutes at 48uC using
random hexonucleotides according to the manufacturer’s instruc-
tions (Applied Biosystems). Real-time PCR of MCP-1 was
performed following the SYBRGreen PCR based protocol as
previously described [11]. Briefly, each sample has been tested in
quadruplicate. The reaction conditions were: 10 min at 95uC (one
cycle), and 15 sec 95uC, 20 sec 60uC, and 30 sec 72uC (40 cycles).
Gene-specific PCR products were continuously measured by
means of an ABI PRISM, 7900 HT Sequence Detection System
(PE Applied Biosystem) and the PCR product sizes were verified
Table 1. Primary Antibodies.
Antibody Specie
Titer
Blotting
Titer
Staining Sources
MCP-1 M 1:1000 1:50 Chemicon Intern. Inc., CA
TGF-b1 R 1:200 1:50 Santa Cruz, CA
Calpain-1 R 1:2500 Sigma, St. Louis, MO
Cytochrome M 1:1000 Cell Signaling Technology Inc. MA
Histone 3 M 1:1000 Cell Signaling Technology Inc. MA
MMP-2 M 1:50 Chemicon Intern. Inc., CA
Collagen I R 1:1000 Rockland Immunochemicals, Inc., PA
b-actin M 1:10000 Sigma-aldrich, Inc. MO
M=mouse; and R=rabbit.
doi:10.1371/journal.pone.0016653.t001
Figure 7. Simplified schematic diagram of a MCP-1/MMP-2/
TGF-b1 loop signaling pathway.
doi:10.1371/journal.pone.0016653.g007
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expression of the ‘‘housekeeping’’ gene, the rRNA 18s, which
did not change with age. Data are expressed as the mean
quantity calculated using the following formula: quantity=
10
–(Ct-Y intersept)/slope value), where Ct represents the threshold cycle
value.
siRNA
For siRNA protocols, pre-annealed purified siRNA probes were
obtained from Dharmacon and were rehydrated prior to
transfection using their standard protocol. The siRNA used were
a pool of four specific RNAs targeting the MCP-1 sequence. A
scramble siRNA pool of probes was used as control. siRNA probes
(25 and 50 nM) were transfected using Gene Silencer (Gene
Therapy Systems). After 24 hours of transfection, VSMC were
harvested, RNA or protein extracted for further analysis, or cells
were fixed and processed for immunofluorescence staining.
Enzyme-linked immunosorbent assay (ELISA)
Secreted TGF-b1 activity from young and old VSMC treated
with or without MCP-1 (50 ng/ml) for 24 hours was assayed with
Quantikine ELISA kit (Cat#: D B100B; R & D Systems Inc. MN).
VSMC invasion
Modified Boyden chambers were equipped with 8 mm pore-size
polycarbonate filters (Costar) coated with Matrigel (BD Bioscienc-
es). VSMC were pre-treated with MCP-1 (50 ng/mL) for 24 hours
in 2.5% FBS. MCP-1 (50 ng/ml) with and without vCCi (100
ng/ml, R&D System Inc. MN) and GM 6001 (15 mM,
Calbiochem International, CA), PDGF-BB (10 ng/mL) or BSA
(control) was added to the lower chamber in 220 mL of MM (MM:
DMEM, 0.1% BSA). VSMC (10
6/mL) were placed in the upper
chamber in 200 mL of MM. The assay was stopped after 4 hours
at 37uC, and cells that had invaded the membrane and migrated
through the filter were fixed on the lower side of the filter, and
stained using the HEMA3 system (Curtin Matheson Scientific).
Four random fields were counted at 400X magnification for each
chamber.
Statistical analysis
All results are expressed as the mean 6 SEM. Statistical analysis
was performed via a T-test when two groups were analyzed, or via
an ANOVA, followed by a Bonferroni post hoc test for multiple
comparisons. A p value of ,0.05 was taken as statistically
significant.
Supporting Information
Figure S1 Cytoskeletal remodeling in the aortic wall
and primary cultured VSMC with aging. A. Representative
Western blots of a-SMA (upper), vimentin (middle), and desmin
(lower) within the arterial wall (left panels) and VSMC (middle and
right panels). B. Average data of a-SMA (upper panel), vimentin
(middle panel), and desmin (lower panel). *p,0.05, vs. 8 mo.
(TIF)
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